These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 18728103)

  • 1. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study.
    Christrup LL; Foster D; Popper LD; Troen T; Upton R
    Clin Ther; 2008 Mar; 30(3):469-81. PubMed ID: 18405786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.
    Borland M; Jacobs I; King B; O'Brien D
    Ann Emerg Med; 2007 Mar; 49(3):335-40. PubMed ID: 17067720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief.
    Toussaint S; Maidl J; Schwagmeier R; Striebel HW
    Can J Anaesth; 2000 Apr; 47(4):299-302. PubMed ID: 10764171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind crossover study.
    Borland ML; Bergesio R; Pascoe EM; Turner S; Woodger S
    Burns; 2005 Nov; 31(7):831-7. PubMed ID: 16005154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtenon block compared to intravenous fentanyl for perioperative analgesia in pediatric cataract surgery.
    Ghai B; Ram J; Makkar JK; Wig J; Kaushik S
    Anesth Analg; 2009 Apr; 108(4):1132-8. PubMed ID: 19299775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK; Taylor D; Messina J; Tremmel L
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns.
    Finn J; Wright J; Fong J; Mackenzie E; Wood F; Leslie G; Gelavis A
    Burns; 2004 May; 30(3):262-8. PubMed ID: 15082356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats.
    Robertson SA; Taylor PM; Sear JW; Keuhnel G
    J Vet Pharmacol Ther; 2005 Feb; 28(1):87-93. PubMed ID: 15720520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.
    Carroll GL; Hooper RN; Boothe DM; Hartsfield SM; Randoll LA
    Am J Vet Res; 1999 Aug; 60(8):986-91. PubMed ID: 10451210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
    Plock N; Facius A; Hartmann L; Baumann S; Nave R
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):495-508. PubMed ID: 23611571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery.
    Stoker DG; Reber KR; Waltzman LS; Ernst C; Hamilton D; Gawarecki D; Mermelstein F; McNicol E; Wright C; Carr DB
    Pain Med; 2008; 9(1):3-12. PubMed ID: 18254761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study.
    Lennernäs B; Frank-Lissbrant I; Lennernäs H; Kälkner KM; Derrick R; Howell J
    Palliat Med; 2010 Apr; 24(3):286-93. PubMed ID: 20015921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
    J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.